Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20034276HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034277HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034280HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047208HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034278HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034282HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034283HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047211HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047209HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034281HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TCGA Plot Options
Drug Information
GeneHTR1D
DrugBank IDDB01392
Drug NameYohimbine
Target IDBE0000659
UniProt IDP28221
Regulation Typepartial agonist
PubMed IDs10611634; 20036429
CitationsMillan MJ, Newman-Tancredi A, Audinot V, Cussac D, Lejeune F, Nicolas JP, Coge F, Galizzi JP, Boutin JA, Rivet JM, Dekeyne A, Gobert A: Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse. 2000 Feb;35(2):79-95.@@Holmes A, Quirk GJ: Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders--the case of yohimbine. Trends Pharmacol Sci. 2010 Jan;31(1):2-7. doi: 10.1016/j.tips.2009.10.003. Epub 2009 Dec 28.
GroupsApproved; Investigational; Vet_approved
Direct ClassificationYohimbine alkaloids
SMILES[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Pathways
PharmGKBPA451946
ChEMBLCHEMBL15245